Available Technologies

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Find technologies available for licensing from UCSF.

Novel Small Molecule Drug for the Treatment of Constipation and Oxalate Kidney Stones

UCSF researchers have developed a novel small molecule drug that specifically targets and inhibits SLC26A3 (DRA), an anion exchanger whose inhibition is expected to have therapeutic benefit in constipation and oxalate kidney stone disease.

“EchoCV”: A Web-Based Fully Automated Echocardiogram Interpretation System

Echo-CV is a novel, fully-automated system for analyzing images obtained from an echocardiogram that can be deployed on the web.

Chimeric Antigen Receptors For Phagocytosis (Car-P)

UCSF researchers have engineered a chimeric antigen receptor for phagocytosis (CAR-P) that promotes engulfment of cancer cells.

T Cell Signature Predictive of Clinical Outcome with Immunomodulatory Treatment

Biomarkers to predict responsiveness to anti-CTLA-4 antibodies

Novel Tumor-targeting Virus for Cancer Therapy

UCSF researchers have developed a novel engineered virus that specifically targets tumor cells using a knottin moiety, to effectively eliminate a number of cancer types.

NOVEL TUMOR SELECTIVE INTERNALIZING ANTIBODIES

Novel human monoclonal antibodies recognize a cell surface antigen that has limited normal tissue expression but is highly overexpressed in several types of cancers, including mesothelioma, melanoma, head and neck cancer, lung cancer, glioblastoma multiforme, pancreatic cancer, ovarian cancer, breast cancer, prostate cancer, cervical cancer, skin cancer and testicular cancer. The antibodies can block tumor invasion, self-renewal and have potential to modulate immune effector cell function.

“PROTAC-SPARK”: A Genetically-encoded Fluorescent Reporter Platform for Studying PROTAC Interaction Kinetics in Living Cells

This novel class of genetically-encoded fluorescent reporters can be used as powerful tools to study kinetics of protein targeting chimeras (PROTACs) in living cells. These bright, reversible reporters have a large dynamic range and fast kinetics, demonstrating significant advantages over traditional FRET-based fluorescent reporters. This highly-customizable reporter system is ideal for designing novel cell assays to quickly test protein-protein interactions with quantitative results.

“CT Mucus Score” - A New Scoring System that Quantifies Airway Mucus Impaction Using CT Scans

A novel method to measure airway mucus plugging using CT images from patients with asthma or chronic obstructive pulmonary disease (COPD) patients.